The data confirm that removing a single EMT transcription factor, such as ZEB1, is not sufficient for reverting the triple–negative mesenchymal breast cancer cells into more differentiated, epithelial‐like clones, but can reduce tumorigenic potential, suggesting that not all pro‐tumorigenic actions of ZEB1 are linked to the EMT. This evidence concerns the gene ZEB1 and breast carcinoma.